Pancreatic Cancer Research

ResearcherTUM KlinikumActive in the last 2 years

Irina Heid

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9834-2820; OpenAlex author ID A5023895087. Sources: OpenAlex.

Their work

Papers
16 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
79
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: 2 papers · 2018: none · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 3 papers

Papers 16

  1. Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarc… Co-author DOI 10.1038/s41591-026-04234-8↗
  2. Contrast enhanced CT and MRI interchangeably reflect tumor characteristics in murine pancreatic cancer. Last author DOI 10.1038/s41598-026-56008-4↗
  3. Hemorrhage-Induced Bias of [18F]FDG PET Signal Interpretation in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.21203/rs.3.rs-10932499/v1↗
  4. Correction to: Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine‑induce… Co-author DOI 10.1007/s00259-025-07195-1↗
  5. Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41551-024-01273-9↗
  6. Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarc… Co-author DOI 10.1038/s41591-024-03054-y↗
  7. Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine-induced hypo-vascular… Co-author DOI 10.1007/s00259-022-05930-6↗
  8. Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s40170-022-00298-5↗
  9. Bcl3 Couples Cancer Stem Cell Enrichment With Pancreatic Cancer Molecular Subtypes. Co-author DOI 10.1053/j.gastro.2021.03.051↗
  10. Functional metabolic phenotyping of human pancreatic ductal adenocarcinoma Co-author DOI 10.1101/2021.07.23.452145↗
  11. Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology. Co-author DOI 10.1172/jci.insight.137809↗
  12. Apparent Diffusion Coefficient (ADC) predicts therapy response in pancreatic ductal adenocarcinoma. First author DOI 10.1038/s41598-017-16826-z↗
  13. Co-clinical Assessment of Tumor Cellularity in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-15-2432↗
  14. Membranous CD24 drives the epithelial phenotype of pancreatic cancer. Co-author DOI 10.18632/oncotarget.9402↗
  15. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/nm.3952↗
  16. Early requirement of Rac1 in a mouse model of pancreatic cancer. Co-author DOI 10.1053/j.gastro.2011.04.043↗

Closest collaborators

The 25 strongest of 79 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rickmer Braren · 15 shared papers, 2015–2026 · strength 1.94
  2. Jens Thomas Siveke · 12 shared papers, 2011–2026 · strength 1.15
  3. Marija Trajkovic‐Arsic · 9 shared papers, 2015–2026 · strength 1.00
  4. Roland Michael Schmid · 9 shared papers, 2011–2026 · strength 0.82
  5. Fabian Karl Lohöfer · 3 shared papers, 2022–2026 · strength 0.59
  6. Stephan A. Hahn · 5 shared papers, 2015–2026 · strength 0.57
  7. Georgios A. Kaissis · 4 shared papers, 2020–2025 · strength 0.54
  8. Matthias Wirth · 5 shared papers, 2015–2026 · strength 0.49
  9. Wilko Weichert · 4 shared papers, 2020–2025 · strength 0.49
  10. Iréne Esposito · 5 shared papers, 2015–2026 · strength 0.49
  11. Hana Algül · 4 shared papers, 2020–2025 · strength 0.47
  12. Bence Sipos · 5 shared papers, 2011–2026 · strength 0.45
  13. Alexander Herner · 4 shared papers, 2015–2026 · strength 0.44
  14. Mert Erkan · 4 shared papers, 2015–2026 · strength 0.43
  15. Jorg H. Kleeff · 4 shared papers, 2015–2026 · strength 0.43
  16. Pawel Karol Mazur · 4 shared papers, 2011–2026 · strength 0.40
  17. Marina Lesina · 3 shared papers, 2011–2026 · strength 0.39
  18. Lucia Liotta · 3 shared papers, 2020–2025 · strength 0.39
  19. Stephano S. Mello · 3 shared papers, 2015–2026 · strength 0.37
  20. Julien Sage · 3 shared papers, 2015–2026 · strength 0.37
  21. Elisabeth Heßmann · 3 shared papers, 2015–2026 · strength 0.37
  22. Laura D Attardi · 3 shared papers, 2015–2026 · strength 0.37
  23. Simone Hausmann · 3 shared papers, 2015–2026 · strength 0.37
  24. Volker Ellenrieder · 3 shared papers, 2015–2026 · strength 0.37
  25. Tyler Jacks · 3 shared papers, 2015–2026 · strength 0.37

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.